|
2011 Journal Article Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assayMcGowan, Eileen M., Alling, Nikki, Jackson, Elise A., Yagoub, Daniel, Haass, Nikolas K., Allen, John D. and Martinello-Wilks, Rosetta (2011). Evaluation of cell cycle arrest in estrogen responsive MCF-7 breast cancer cells: Pitfalls of the MTS assay. PLoS ONE, 6 (6) e20623, e20623.1-e20623.8. doi: 10.1371/journal.pone.0020623 |
|
2011 Book Chapter Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironmentKuphal, Silke and Haass, Nikolas K. (2011). Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment. Melanoma Development: Molecular Biology, Genetics and Clinical Application. (pp. 181-215) edited by Anja Bosserhoff. Vienna, Austria: SpringerWienNewYork. doi: 10.1007/978-3-7091-0371-5 |
|
2011 Book Chapter Egretta schistacea: KuestenreiherHaass, N. K. and Bauer, H.-G. (2011). Egretta schistacea: Kuestenreiher. Nicht-Singvögel: Rheidae (Nandus) - Phoenicopteridae (Flamingos). (pp. 266-268) edited by Jochen Hölzinger and Hans-Günther Bauer. Stuttgart, Germany: Ulmer Eugen Verlag. |
|
2010 Conference Publication Tropomyosin Tm5NM1: A novel target for cancer therapyStehn, J., Schevzov, G., Bonello, T., McCluskey, A., Haass, N., Palmer, S., Hardeman, E., Allanson, M., Reeve, V. and Gunning, P. (2010). Tropomyosin Tm5NM1: A novel target for cancer therapy. 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Berlin Germany, Nov 16-19, 2010. PERGAMON-ELSEVIER SCIENCE LTD. doi: 10.1016/S1359-6349(10)72041-3 |
|
2010 Conference Publication Tight Junction - specific proteins are absent from melanoma while ZO-1 is widely expressedBohner, C., Vidal-y-Sy, S., Moll, I, von den Driesch, P., Haass, N. K., Schaider, H. and Brandner, J. M. (2010). Tight Junction - specific proteins are absent from melanoma while ZO-1 is widely expressed. WILEY-BLACKWELL. |
|
2010 Journal Article Genetics of basal cell carcinomaDe Zwaan, Sally E. and Haass, Nikolas K. (2010). Genetics of basal cell carcinoma. Australasian Journal of Dermatology, 51 (2), 81-92. doi: 10.1111/j.1440-0960.2009.00579.x |
|
2010 Conference Publication Modification of the sphingosine kinase pathway as a novel therapeutic approach for melanomaDouglas, G., Kaczorowski, D., McGowan, E., Anfosso, A., Xia, P., Weninger, W. and Haass, N. K. (2010). Modification of the sphingosine kinase pathway as a novel therapeutic approach for melanoma. 37th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Luebeck Germany, Feb 18-20, 2010. ELSEVIER GMBH, URBAN & FISCHER VERLAG. |
|
2010 Journal Article PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasLee, John T., Li, Ling, Brafford, Patricia A., Van Den Eijnden, Marcia, Halloran, Molly B., Sproesser, Katrin, Haass, Nikolas K., Smalley, Keiran S. M., Tsai, James, Bollag, Gideon and Herlyn, Meenhard (2010). PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell and Melanoma Research, 23 (6), 820-827. doi: 10.1111/j.1755-148X.2010.00763.x |
|
2010 Journal Article Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibilityCocciolone, Raymond A., Crotty, Kerry A., Andrews, Lesley, Haass, Nikolas K. and Moloney, Fergal J. (2010). Multiple desmoplastic melanomas in Birt-Hogg-Dubé syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. Archives of Dermatology, 146 (11), 1316-1318. doi: 10.1001/archdermatol.2010.333 |
|
2010 Journal Article Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironmentHaass, Nikolas K., Ripperger, D., Wladykowski, E., Dawson, P., Gimotty, P. A., Blome, C., Fischer, F., Schmage, P., Moll, I. and Brandner, Johanna M. (2010). Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironment. Histochemistry and Cell Biology, 133 (1), 113-124. doi: 10.1007/s00418-009-0654-5 |
|
2009 Conference Publication Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but cytotoxic when combined with docetaxel leading to tumour regression in vitro and in vivoHaass, Nikolas K., Sproesser, Katrin, Nguyen, Thiennga K., Contractor, Rooha, Herlyn, Meenhard and Smalley, Keiran S. M. (2009). Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but cytotoxic when combined with docetaxel leading to tumour regression in vitro and in vivo. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney Australia, May 21-22, 2008. NATURE PUBLISHING GROUP. |
|
2009 Conference Publication Connexin expression patterns in the epidermal tumour microenvironment of melanoma are valuable biomarkers for diagnosis and prognosisHaass, N. K., Ripperger, D., Wladykowski, E., Dawson, P., Gimotty, P. A., Reich, C., Fischer, F., Schmage, P., Moll, I. and Brandner, J. M. (2009). Connexin expression patterns in the epidermal tumour microenvironment of melanoma are valuable biomarkers for diagnosis and prognosis. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney Australia, May 21-22, 2008. NATURE PUBLISHING GROUP. |
|
2009 Conference Publication NOXA inhibits melanoma growth and invasion in 3D modelsMohana-Kumaran, N., Lucas, K. M., Weninger, W., Allen, J. D. and Haass, N. K. (2009). NOXA inhibits melanoma growth and invasion in 3D models. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney Australia, May 21-22, 2008. NATURE PUBLISHING GROUP. |
|
2009 Conference Publication Tight junction proteine in merkel cell carcinomaFuchs, F., Moll, I, Haass, N. K., Houdek, P., Wladykowski, E. and Brandner, J. M. (2009). Tight junction proteine in merkel cell carcinoma. MALDEN: WILEY-BLACKWELL PUBLISHING, INC. |
|
2009 Conference Publication Novel small molecule kinase inhibitors with potent and specific anti-melanoma activityHaass, N. K., Smalley, K. S., Lee, J. T., Weninger, W. and Herlyn, M. (2009). Novel small molecule kinase inhibitors with potent and specific anti-melanoma activity. 69th Annual Meeting of the Society-of-Investigative-Dermatology, Montreal Canada, May 06-09, 2009. NATURE PUBLISHING GROUP. |
|
2009 Conference Publication ZO-1 in malignant melanoma and adjacent epidermisBohner, C., Haass, N. K., Ripperger, D., Wladykowski, E., Moll, I. and Brandner, J. (2009). ZO-1 in malignant melanoma and adjacent epidermis. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL. |
|
2009 Conference Publication Targeted therapy of melanoma: Novel kinase inhibitors with potent and specific anti-melanoma activityHaass, N. K., Smalley, K. S., Lee, J. T. and Herlyn, M. (2009). Targeted therapy of melanoma: Novel kinase inhibitors with potent and specific anti-melanoma activity. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL. |
|
2009 Conference Publication Usability of Connexin 26, 30 and 43 as markers for diagnosis and prognosis of malignant melanomaHaass, N. K., Ripperger, D., Wladykowski, E., Fischer, F., Schmage, P., Moll, I. and Brandner, J. M. (2009). Usability of Connexin 26, 30 and 43 as markers for diagnosis and prognosis of malignant melanoma. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL. |
|
2009 Journal Article Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to TherapyHaass, Nikolas K. and Smalley, Keiran S. M. (2009). Melanoma Biomarkers Current Status and Utility in Diagnosis, Prognosis, and Response to Therapy. Molecular Diagnosis and Therapy, 13 (5), 283-296. doi: 10.1007/BF03256334 |
|
2009 Journal Article Melanocytes: From morphology to applicationSantiago-Walker, A., Li, L., Haass, N. K. and Herlyn M. (2009). Melanocytes: From morphology to application. Skin Pharmacology and Physiology, 22 (2), 114-121. doi: 10.1159/000178870 |
